Antimicrobial Drugs: Principles, Mechanisms, and Resistance

Antimicrobial Drugs: Introduction and Historical Context

Definition and Importance

Antimicrobial drugs are therapeutic compounds designed to kill or inhibit the growth of microbes, thereby preventing or treating infectious diseases. Their development has revolutionized modern medicine, drastically reducing mortality from infections that were once often fatal.

• Antimicrobial drug: Any substance that kills or inhibits the growth of microorganisms, including bacteria, viruses, fungi, and parasites.

• Antibiotic: A type of antimicrobial specifically targeting bacteria.

• Antimicrobials are categorized by the type of pathogen they target: antibacterials, antivirals, antifungals, and antiparasitic agents.

Discovery of Penicillin

The discovery of penicillin marked the beginning of the antibiotic era. In 1928, Alexander Fleming observed that a mold, later identified as Penicillium, inhibited the growth of Staphylococcus aureus on a culture plate. This led to the isolation and mass production of penicillin, the first clinically used antibiotic.

• Zone of inhibition: The clear area around the mold where bacterial growth was prevented, indicating antimicrobial activity.

Spectrum of Activity and Empiric Therapy

Spectrum of Activity

The spectrum of activity refers to the range of microbes an antimicrobial drug can affect.

• Broad-spectrum: Effective against a wide variety of microbes (e.g., both Gram-positive and Gram-negative bacteria).

• Narrow-spectrum: Targets a limited group of microbes, minimizing disruption to normal microbiota but requiring precise pathogen identification.

• Limited-spectrum: Effective against a single organism or disease.

Empiric Therapy

Empiric therapy involves starting treatment with a broad-spectrum drug based on clinical judgment before the specific pathogen is identified. Once laboratory results are available, therapy should be adjusted to a narrow-spectrum agent to minimize side effects and resistance development.

Classification and Modification of Antimicrobial Drugs

Sources of Antimicrobial Drugs

• Naturally occurring: Produced by microorganisms (e.g., soil bacteria and fungi).

• Synthetic: Fully manufactured by chemical processes.

• Semisynthetic: Chemically modified derivatives of natural antibiotics to improve efficacy, spectrum, or pharmacokinetics.

Drug Modification and Generations

Chemical modification of antibiotics (e.g., adding R groups) leads to new generations with improved properties such as broader spectrum, increased stability, and reduced toxicity.

• Example: Ampicillin and amoxicillin are semisynthetic derivatives of penicillin G, with broader activity due to enhanced ability to penetrate Gram-negative cell walls.

Principles of Antimicrobial Drug Action

Selective Toxicity and Therapeutic Index

Antimicrobial drugs must exhibit selective toxicity, targeting microbial structures or functions not present in the host. The therapeutic index (TI) is the ratio of the toxic dose to the therapeutic dose, indicating the drug's safety margin.

• High TI: Wide margin of safety; less risk of toxicity.

• Low TI: Narrow margin; higher risk of adverse effects.

Toxicity Considerations

Antimicrobials can cause toxicity to key organs involved in drug metabolism and elimination, especially the liver (hepatotoxicity) and kidneys (nephrotoxicity), as well as disrupt the gut microbiome.

• Hepatotoxicity: Drug-induced liver injury.

• Nephrotoxicity: Drug-induced kidney damage.

• Gut microbiome toxicity: Disruption of normal intestinal flora.

Routes of Administration

• Oral: Preferred for convenience and cost; requires stability in the stomach and absorption in the intestines.

• Parenteral: Non-oral routes (e.g., intravenous, intramuscular, subcutaneous, intradermal) allow rapid drug delivery but require injections.

Drug Half-Life and Interactions

• Half-life: Time required for half the drug to be eliminated from the body; determines dosing frequency.

• Drug interactions: Some antimicrobials interact with other drugs, foods, or supplements, affecting efficacy or causing adverse effects.

Mechanisms and Targets of Antimicrobial Drugs

Antibacterial Drug Mechanisms

Antibacterial drugs exploit differences between prokaryotic and eukaryotic cells, targeting bacterial-specific structures and processes.

• Cell wall synthesis inhibitors (e.g., penicillins, cephalosporins)

• Protein synthesis inhibitors (e.g., tetracyclines, macrolides)

• Nucleic acid synthesis inhibitors (e.g., quinolones, rifamycins)

• Cell membrane disruptors (e.g., polymyxins)

• Metabolic pathway inhibitors (e.g., sulfa drugs, trimethoprim)

Bacteriostatic vs. Bactericidal Drugs

• Bacteriostatic: Inhibit bacterial growth; rely on the host immune system for pathogen clearance.

• Bactericidal: Kill bacteria directly; useful in immunocompromised patients or severe infections.

CATEGORY	BACTERICIDAL	BACTERIOSTATIC
Definition	Substance that kills bacteria	Substance that inhibits bacterial growth
Minimum Concentration	MBC (minimum bactericidal concentration)	MIC (minimum inhibitory concentration)
Number of Bacterial Cells	Number decreases	Number remains the same
Viability of Bacteria	Bacteria die	Bacteria remain viable
Activation of Immune System	No effect	Helps immune system
High Dose Effect	Kills all bacterial cells	May act as bactericidal at high doses
Low Dose Effect	May act as bacteriostatic	May not be effective
Reversibility	Irreversible	Reversible

Antiviral, Antifungal, and Antiparasitic Drugs

• Antivirals: Target steps in viral replication (attachment, penetration, uncoating, replication, assembly, release) or stimulate host immune responses. Most effective against actively replicating viruses.

• Antifungals: Target fungal-specific structures such as ergosterol in cell membranes, cell wall synthesis, or nucleic acid synthesis.

• Antiparasitics: Target unique features of protozoa or helminths, but development is challenging due to similarities with host cells and complex life cycles.

Assessing Sensitivity to Antimicrobial Drugs

Antibiotic Susceptibility Testing (AST)

AST determines which antimicrobials are effective against a specific pathogen. Common methods include:

• Kirby-Bauer disk diffusion: Measures zone of inhibition to determine susceptibility.

• E-test: Uses a drug gradient strip to determine minimum inhibitory concentration (MIC).

• Broth dilution: Determines MIC and minimum bactericidal concentration (MBC) by serially diluting drugs in broth and assessing bacterial growth and viability.

Antimicrobial Drug Resistance and Stewardship

Types of Resistance

• Intrinsic resistance: Natural, due to inherent structural or functional characteristics (e.g., lack of cell wall, biofilm formation, impermeable outer membrane).

• Acquired resistance: Due to genetic mutations or acquisition of resistance genes via horizontal gene transfer (conjugation, transformation, transduction).

Mechanisms of Acquired Resistance

• Alteration of drug target (e.g., mutation in binding site)

• Inactivation of drug (e.g., enzymatic degradation or modification)

• Reduced drug concentration (e.g., decreased permeability, efflux pumps)

Superbugs and Superinfections

• Superbugs: Microbes resistant to multiple antimicrobials.

• Superinfection: Secondary infection by resistant organisms after normal microbiota are eliminated by broad-spectrum antibiotics.

Factors Accelerating Resistance

• Noncompliance with prescribed regimens

• Misuse and overuse of antimicrobials in healthcare and agriculture

• Unregulated antibiotic use in some regions

Antimicrobial Stewardship

Stewardship programs promote the appropriate use of antimicrobials to improve patient outcomes, reduce resistance, and decrease the spread of multidrug-resistant organisms. Key strategies include:

• Limiting unnecessary prescriptions

• Using narrow-spectrum drugs when possible

• Educating patients and healthcare workers

• Proper hand hygiene and infection control

Summary Table: Types of Antimicrobial Therapy

Type of Therapy	Description
Prophylaxis	Antibiotics used to prevent infection
Empiric	Organism is unknown but syndrome is known
Pathogen-directed	Organism is known but susceptibility is unknown
Susceptibility-guided	Organism is known and susceptibility is known

Additional info: This guide covers foundational concepts in antimicrobial drugs, including their discovery, classification, mechanisms of action, toxicity, resistance, and stewardship. Understanding these principles is essential for effective clinical practice and combating the global threat of antimicrobial resistance.